When it comes to innovation in the development of new medicines, a key focus is on Real World Evidence – data based on what's really happening in the real world (aka: reality). Unfortunately, when it comes to healthcare policy, ‘real' seems to be conveniently ignored when it doesn't suit the shibboleths of political agendas. Case in point – the Inflation Reduction Act (IRA) and its call for government price controls for certain prescription medicines.
Read Full Article »
